Richard Ginn - Apr 26, 2022 Form 3 Insider Report for Tenon Medical, Inc. (TNON)

Role
Chief Technology Officer, Director
Signature
/s/ Richard Ginn
Stock symbol
TNON
Transactions as of
Apr 26, 2022
Transactions value $
$0
Form type
3
Date filed
4/26/2022, 09:34 PM
Next filing
May 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TNON Common Stock 572K Apr 26, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TNON Stock Options Apr 26, 2022 Common Stock 56.5K $5.20 Direct F2, F3
holding TNON Stock Options Apr 26, 2022 Common Stock 5.5K $7.06 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 30,738 shares of common stock issuable upon the automatic conversion of a convertible note on the closing of the initial public offering of Tenon Medical, Inc. to occur on April 29, 2022.
F2 Richard Ginn was granted an option to purchase 113,000 shares (or 56,500 shares after the 1-for-2 reverse stock split was effectuated on April 6, 2022) of common stock at an exercise price of $2.60 (or $5.20 post-split) per share with a grant date of May 1, 2021, subject to monthly equal vesting over a three-year period commencing April 1, 2021.
F3 18,833 shares of common stock underlying stock options granted on May 1, 2021 have vested and are exercisable as of April 26, 2022.
F4 Richard Ginn was granted an option to purchase 10,998 shares (or 5,499 shares post-split) of common stock at an exercise price of $3.53 (or $7.06 post-split), per share with a grant date of July 19, 2021, subject to monthly equal vesting over a three-year period commencing July 19, 2021.
F5 1,374 shares of common stock underlying stock options granted on July 19, 2021 have vested and are exercisable as of April 26, 2022.